Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Chronic nepicastat is an effective adjunct therapy for heart failure

Aug. 31, 1998

Phase II study establishes feasibility, safety of pioneering restenosis treatment

Aug. 28, 1998

ETA antagonism with LU-135252 may provide novel antiischemic therapy

Aug. 28, 1998

Bayer reports new agents for treating cardiovascular disease

Aug. 28, 1998

CIBIS-II study results confirm benefits of beta-blockade in heart failure

Aug. 27, 1998

MOXCON study will test the efficacy of SIRAs in treating heart failure

Aug. 27, 1998

News from ACS: PD-180988 is a potent and selective ETA antagonist

Aug. 26, 1998

Pfizer discovers new treatments for atherosclerosis and related disorders

Aug. 26, 1998

HERS study results now in -- results counter expectations

Aug. 25, 1998

MDL-103294 and related antioxidants described by Hoechst Marion Roussel

Aug. 24, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...
How to Summit up? Dis-Harmoni on ivonescimab NSCLC phase III
BioWorld
Wall Street pundits were divided about the likely fate of ivonescimab, Summit Therapeutics Inc.’s bispecific antibody partnered with Akeso Pharmaceuticals Inc.,...